Syneos Health to Present at the 38th Annual J.P. Morgan Healthcare ConferenceHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Syneos Health to Present at the 38th Annual J.P. Morgan Healthcare ConferenceGlobeNewswireJanuary 3, 2020ReblogShareTweetShareMORRISVILLE, N.C., Jan. 03, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced that Chief Executive Officer Alistair Macdonald is scheduled to present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Wednesday, January 15, 2020, at 8:00 a.m. PST.A live webcast of the event, along with a link to the presentation materials and archived audio replay of the presentation, will be available on the Company’s Investor Relations website at investor.syneoshealth.com.About Syneos HealthSyneos Health® (SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast. Contacts Investor Relations:     Press/Media:
Ronnie Speight     Danielle DeForge
Senior Vice President, Investor Relations     Executive Director, External Communications
+1 919 745 2745     +1 202 210 5992
Investor.Relations@syneoshealth.com     danielle.deforge@syneoshealth.com  ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextCoronavirus epidemic takes billion-dollar economic toll on Seattle-area businessesAmerican City Business JournalsHouse committee to explore benefits of blockchain for small businesses next weekThe BlockBetter Business Bureau Says Email Compromise Scam Can Happen to AnyonePR NewswireWFBH infectious disease expert: 'Cat is out of the bag' on COVID-19American City Business JournalsW.H.O. recommends these coronavirus workplace precautionsFox BusinessRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoMost face masks won’t protect you from the coronavirusYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceWhat to watch in the markets: Friday, February 28Yahoo Finance VideoStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo Finance